Andere Sprachen 2invest AG

Aktien

A3H3L4

DE000A3H3L44

2INV

Markt geschlossen - Xetra Andere Börsenplätze 17:36:19 06.12.2023			% 5 Tage	% 1. Jan.
5,9 ^EUR	0,00 %		-3,28 %	-33,41 %

17.08.	2invest AG meldet Ergebnis für das Halbjahr bis zum 30. Juni 2023	CI
06.04.	2invest AG meldet Ergebnis für das am 31. Dezember 2022 beendete Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

2invest AG Reports Earnings Results for the Half Year Ended June 30, 2023	17.08.
2invest AG Reports Earnings Results for the Full Year Ended December 31, 2022	06.04.
Theta Gold Mines Limited (ASX:TGM) Issue of New Call Options to 2Invest AG	2022
2invest AG Reports Earnings Results for the Half Year Ended June 30, 2022	2022
Theta Gold Mines Limited (ASX:TGM) Option to Extend Secure Bond Maturity Date	2022
2invest AG Reports Earnings Results for the Full Year Ended December 31, 2021	2022
Heqet Therapeutics S.R.L. announced that it has received £6.6 million in funding from Claris Ventures SGR SpA, 2invest AG	2022
Kither Biotech s.r.l. announced that it has received €18.5 million in funding from a group of investors	2022
2invest : Preliminary annual results as of 31 December 2021	2022
2invest : Change of forecast for the financial year 2021	2021
Revocation of the admission to the Prime Standard	2021
Leucid Bio Ltd announced that it has received ?11.5 million in funding from Epidarex Capital, Vulpes Investment Management Private Ltd, 2invest AG, British Business Investments Ltd., Sofinnova Partners SAS	2021
2Invest Ag Reports Earnings Results for the Half Year Ended June 30, 2021	2021
2invest : Preliminary half-year results as of 30.06.2021	2021
2invest : Report of the Supervisory Board of 2invest AG for the financial year from 1 January 2020 to 31 December 2020	2021
4basebio : Quarterly statement as at 31 March 2021 published	2021
4basebio : Application for change from Prime Standard to General Standard	2021
4basebio : Implementation of the reverse stock split of 4basebio AG	2021
4basebio : KROMI takeover offer will not be pursued further	2021
4basebio : Preliminary annual result as of 31.12.2020	2021

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen 2invest AG

Aktien

A3H3L4

DE000A3H3L44

2INV

Andere Sprachen

Filter